Indoor farming is an important part of modern agriculture for producing crops in a controlled environment. There is an increasing growth for indoor farming globally propelled by the rising world population along with a consequent demand for consistent food supplies. Conventional agriculture is suitable for areas with sufficient land and water supply. Since the percentage of arable land and water supply to support conventional agriculture is diminishing, the demand for indoor farming is heightening. Indoor farms can help to grow the total crop yield per unit area by utilizing the stacked layers of potted seeds, and this is further expected to drive the market. Indoor farming mainly implements methods, including aquaponics, aeroponics, and hydroponics also utilizes artificial lighting such as LED lights for adequate light levels and nutrients. Indoor farming method or concept further employs various technologies that become the means of operation. For instance, to collect data, indoor farming depends on the Internet of Things (IoT), GPS, and other sensor-based technologies, which allow seamless data collection. For data analysis, several farm management software and artificial intelligence (AI) based tools can be utilized to make sense of the collected data, and later autonomous machines and other mechanical equipment can be employed to take necessary actions.

CRISPR is a technology that is used in gene editing enabling researchers and scientists globally to alter DNA sequence and modify gene function with ease. CRISPR gene editing was adopted from the antivirus immunity system of single-celled microorganisms, namely archaea and bacteria. Fragments of alien DNA, known as a spacer, are incorporated and transcribed into guide crRNA (CRISPR RNAs) to specifically target and cleave the genome of the virus and other foreign bodies using Cas proteins. In other words, the CRISPR/Cas9 system directs the Cas9 nuclease to form a site-directed double-strand DNA break using a small RNA molecule that results in permanent alterations of the genomic target sequence and repair the damage caused to DNA. These components, when transferred into more complex organisms, enable gene editing or modifications.

Epigenetics modification, including histone modification, DNA methylation, and RNA-mediated processes modification, are key to impact gene expression primarily at the level of transcription; disturbing any of three marks that contribute to epigenetic modification can cause abnormal activation or silencing of genes. However, other steps in the process (for example, translation) may also be regulated epigenetically. The current study aims to assess the global epigenetics market by focusing on products (consumables, instruments, software) catering to end users, including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and other end users. The current market for epigenetics is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc, Bio-Rad Laboratories, Inc, PerkinElmer Inc, Agilent Technologies, Inc, F. Hoffmann-La Roche Ltd., Exact Sciences Corporation, Merck Group, Abcam plc., MDxHealth, Pacific Biosciences of California, Inc, QIAGEN N.V., Zymo Research Corporation, Active Motif, and Promega Corporation among others.

Digitalization is defined as the ability to harness collective technological advances in computing power, data collection, processing, storage, and networking between computer devices. The term must be differentiated from digitization, which simply means the conversion of analog to digital, e.g., converting a printed photograph into a JPEG* file. Defense forces have always pursued digitalization; however, its adoption has lagged behind commercial industries in recent times. Historically, computers have been used to manage logistics, supply inventory, pay wages, and maintain personnel records. There is also a rapid increase in digital adoption on the battlefield with advances in automated processing and sensor technologies.

The study defines cancer microbiome as the aggregate of microorganisms living in or on the human body along with their genomes that are influencing cancer manifestation and progression. Cancer microbiome sequencing has increasingly become an area of interest for the research community, which has the potential to revolutionize cancer care, largely due to studies that have significantly correlated the microbiome’s involvement in cancer manifestation. This study aims at deciphering the potential of the cancer microbiome sequencing and its larger role in bolstering the current era of precision medicine.

Biopesticides provide farmers with efficient instruments on both fronts by delivering highly effective pest and disease management solutions while minimising environmental impact, and their active and inert ingredients are generally recognised as safe. Aside from the microbial content, carrier media for biopesticide formulation include a variety of organic materials such as animal broth, organic materials, or organic waste products.

2016年，河南深入实施《中国制造2025河南行动纲要》，全力推进制造业供给侧结构性改革，工业经济保持平稳增长，产业结构继续优化，产品层次稳步提升，企业效益明显改善，利润总额增速稳步加快。预计2017年，河南规模以上工业增加值同比增长7.5%左右。围绕建设先进制造业强省，河南需要在提高政策含金量、推广新型制造模式、构建创新网络、培养高素质人才、拓展融资渠道、强化战略研究等方面创新发展思路。

本文在总结河南省制造业发展成就的基础上，深入分析新常态下河南省先进制造业发展面临的形势，指出建设先进制造业强省要聚焦重点领域，因业施策，分类引导，重点突破，并从八大产业领域给出建设先进制造业强省的重要途径。

2019年，全国药品流通市场销售规模稳步增长，增速略有回升。大型药品批发企业销售加速增长，集中度继续提升；零售行业集中度、连锁率进一步提高；医药物流向智慧物流迈进，专业化服务能力显著提升；医药电商进入快速成长阶段。2020年，受整体经济环境和各种因素影响，药品流通行业增长将承受更大压力。

随着药品集中采购等政策的实施以及大数据等新技术的应用，我国药品流通行业实现了多重转型。本文对药品流通行业转型的政策及社会背景进行梳理，归纳了当前药品流通行业转型的主要方式与表现，包括商业模式转型、行业集中度提高、供应链整合以及“互联网+药品流通”等新业态发展，并指出了转型过程仍存在价格管制未实现预期效果、“4+7”药品带量采购的价格形成机制需要进一步完善等问题。在转型方向预判的基础上，提出未来药品流通行业转型的管理对策。